A detailed history of New York State Common Retirement Fund transactions in Pulmonx Corp stock. As of the latest transaction made, New York State Common Retirement Fund holds 15,345 shares of LUNG stock, worth $127,210. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,345
Previous 15,378 0.21%
Holding current value
$127,210
Previous $143,000 32.17%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$5.77 - $9.82 $190 - $324
-33 Reduced 0.21%
15,345 $97,000
Q1 2024

May 07, 2024

SELL
$8.71 - $14.65 $18,439 - $31,014
-2,117 Reduced 12.1%
15,378 $143,000
Q4 2023

Feb 01, 2024

BUY
$7.89 - $13.14 $34,013 - $56,646
4,311 Added 32.7%
17,495 $223,000
Q3 2023

Nov 07, 2023

BUY
$9.88 - $14.0 $1,067 - $1,512
108 Added 0.83%
13,184 $136,000
Q2 2023

Aug 07, 2023

SELL
$10.78 - $13.65 $99,531 - $126,030
-9,233 Reduced 41.39%
13,076 $171,000
Q1 2023

May 02, 2023

SELL
$7.49 - $12.54 $20,223 - $33,858
-2,700 Reduced 10.8%
22,309 $249,000
Q4 2022

Jan 30, 2023

BUY
$4.92 - $17.35 $137 - $485
28 Added 0.11%
25,009 $211,000
Q3 2022

Nov 08, 2022

BUY
$15.35 - $23.99 $44,361 - $69,331
2,890 Added 13.08%
24,981 $416,000
Q2 2022

Aug 04, 2022

SELL
$14.0 - $27.95 $490 - $978
-35 Reduced 0.16%
22,091 $325,000
Q1 2022

May 05, 2022

BUY
$21.13 - $35.65 $80,336 - $135,541
3,802 Added 20.75%
22,126 $549,000
Q4 2021

Feb 02, 2022

SELL
$29.72 - $45.1 $1,367 - $2,074
-46 Reduced 0.25%
18,324 $588,000
Q3 2021

Nov 02, 2021

SELL
$35.98 - $44.48 $126,757 - $156,703
-3,523 Reduced 16.09%
18,370 $661,000
Q2 2021

Aug 02, 2021

BUY
$37.61 - $48.0 $123,473 - $157,584
3,283 Added 17.64%
21,893 $966,000
Q1 2021

May 11, 2021

BUY
$44.0 - $67.54 $418,440 - $642,305
9,510 Added 104.51%
18,610 $851,000
Q4 2020

Feb 08, 2021

BUY
$39.31 - $69.02 $357,721 - $628,082
9,100 New
9,100 $628,000

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $309M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.